AC Immune (NASDAQ:ACIU) Downgraded to Sell at StockNews.com

AC Immune (NASDAQ:ACIU – Get Rating) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. Separately, HC Wainwright restated a “buy” rating and set a $16.00 price objective on shares of AC Immune in a research report on […]

Related Keywords

Banque Cantonale Vaudoise ,Ac Immune Company Profile ,Virtu Financial ,Balyasny Asset Management ,Kingsbury Capital Investment Advisors ,Get Rating ,Trading Down ,Asset Management ,Cantonale Vaudoise ,Capital Investment Advisors ,Jane Street Group ,Ac Immune ,Nasdaq Aciu ,Raciu ,Medical ,Downgrade ,Stocknews Com ,